Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Idacorp

Stocks Showing Improved Relative Strength: IDACORP

A Relative Strength Rating upgrade for IDACORP shows improving technical performance. Will it continue?

Investors Business Daily

IDACORP Gets Relative Strength Rating Upgrade

IDACORP Gets Relative Strength Rating Upgrade

IDACORP shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

IDACORP Earns Technical Rating Upgrade

IDACORP Earns Technical Rating Upgrade

A Relative Strength Rating upgrade for IDACORP shows improving technical performance. Will it continue?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

IDACORP Sees Composite Rating Move Up To 96

On Friday, IDACORP got an upgrade for its IBD SmartSelect Composite Rating from 89 to 96.

Investors Business Daily

IDACORP Getting Closer To Key Technical Benchmark

A Relative Strength Rating upgrade for IDACORP shows improving technical performance. Will it continue?

Investors Business Daily

Stocks Flashing Renewed Technical Strength: IDACORP

IDACORP sees its Relative Strength Rating hit the 80-plus level.

Investors Business Daily

Stocks Generating Improved Relative Strength: IDACORP

A Relative Strength Rating upgrade for IDACORP shows improving technical performance. Will it continue?

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

IDACORP Earns Relative Strength Rating Upgrade; Hits Key Threshold

IDACORP Earns Relative Strength Rating Upgrade; Hits Key Threshold

IDACORP shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.

Investors Business Daily

IDACORP Earns Technical Rating Upgrade

IDACORP Earns Technical Rating Upgrade

A Relative Strength Rating upgrade for IDACORP shows improving technical performance. Will it continue?

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Idacorp's Return On Capital Employed Insights

Idacorp's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Idacorp (NYSE:IDA) earned $46.18 million, a 40.62% increase from the preceding quarter. Idacorp also posted a total of $344.29 million in sales, a 2.77% increase since Q4.

Idacorp: Q1 Earnings Insights

Idacorp: Q1 Earnings Insights

Idacorp (NYSE:IDA) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Idacorp's Earnings Outlook

Idacorp's Earnings Outlook

Idacorp (NYSE:IDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Idacorp will report an earnings per share (EPS) of $0.92.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

Friday Is Your Last Chance To Buy Idacorp Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Idacorp (NYSE:IDA).

Looking Into Idacorp's Return On Capital Employed

Pulled from Benzinga Pro data, Idacorp (NYSE:IDA) posted Q4 earnings of $32.84 million, an increase from Q3 of 66.47%. Sales dropped to $335.01 million, a 25.04% decrease between quarters.

Recap: Idacorp Q4 Earnings

Idacorp (NYSE:IDA) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Idacorp's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from Idacorp (NYSE:IDA).

Get all your
news in one place.

100’s of premium titles.
One news app.

Organisations

Investor Business Daily

Vertex Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play